Question explored with the scientific record
Is synthetic folic acid bad for people with vitamin b12 deficiency who also have a heart stent at 86 years old?
For an 86-year-old with B12 deficiency and a heart stent, synthetic folic acid carries a real risk of masking B12 deficiency and has been linked to increased cancer and death in heart patients, so it should be avoided unless a doctor has specifically ruled out B12 deficiency first.
The core danger is that folic acid can correct the anemia of B12 deficiency while letting the neurological damage continue unchecked. A 2021 review explicitly names "masked B12 deficiency" as a risk of excessive folic acid intake [1]. At 86, B12 deficiency is already common, often worsened by stomach-acid drugs many older adults take [5]. Adding folic acid without first confirming B12 status is a gamble with the person's nerves and brain.
For someone with a heart stent, the safety signal is even more concerning. A 2009 JAMA study of patients with ischemic heart disease found that those given folic acid and B12 had a 21% higher risk of cancer and an 18% higher risk of death compared to those not given the vitamins [2]. These are not small numbers. The study was in people with heart disease, which matches this case. While the study used a combination pill, the cancer signal was linked to folic acid.
The evidence for benefit in this specific situation is weak. A meta-analysis of coronary artery disease patients found folic acid improved a lab measure of blood-vessel function (flow-mediated dilation) but did not change blood pressure or heart rate [4]. Improving a surrogate lab value is not the same as preventing a heart attack or death. The same meta-analysis noted high statistical inconsistency in its results, meaning the findings are not reliable [4].
| Outcome | Folic acid group | No folic acid | Hazard ratio (95% CI) |
|---|---|---|---|
| Cancer incidence | 629 events | 473 events | 1.21 (1.03–1.41) |
| Cancer mortality | 236 events | 100 events | 1.38 (1.07–1.79) |
| All-cause mortality | 548 events | 473 events | 1.18 (1.04–1.33) |
Data from the 2009 JAMA trial in patients with ischemic heart disease [2].
If B12 deficiency is confirmed, the correct treatment is B12 itself, not folic acid. A 2019 trial in older adults with mild cognitive impairment found that giving B12 and folic acid together improved cognition and lowered inflammation, but that was in people who were not B12-deficient at baseline [3]. That study does not apply here. The safe approach is to measure B12 and homocysteine levels first, treat any B12 deficiency directly, and only then consider folic acid if a separate folate deficiency is documented.
My call: synthetic folic acid is not safe for this person unless B12 deficiency has been ruled out and a separate folate deficiency is proven. Confidence: high.
Sources used 5
-
Gebelikte Folik Asit, B12 Vitamini, D Vitamini ve İyot Destekleri Kullanmak Gerekli Midir? Olası Riskler
Excessive intake of folic acid, vitamin B12, vitamin D, and iodine during pregnancy may increase risks including carcinogenicity, masked B12 deficiency, teratogenicity, and thyroid dysfunction; supplementation should thus be individualized.
DOI: 10.17517/ksutfd.832401 -
Cancer Incidence and Mortality After Treatment With Folic Acid and Vitamin B<sub>12</sub>
This study evaluates the effects of folic acid and vitamin B12 treatment on cancer incidence and mortality in patients with ischemic heart disease, revealing an association with increased cancer outcomes and all-cause mortality.
DOI: 10.1001/jama.2009.1622 -
Effects of Folic Acid and Vitamin B12, Alone and in Combination on Cognitive Function and Inflammatory Factors in the Elderly with Mild Cognitive Impairment: A Single-blind Experimental Design
A randomized, single-blind trial in elderly Chinese adults with mild cognitive impairment (MCI) shows that six months of folic acid and vitamin B12, especially in combination, improve cognitive function and lower inflammatory markers compared with no treatment.
DOI: 10.2174/1567205016666190725144629 -
GW24-e1838 Efficacy of folic acid supplementation alone on endothelial function and plasma homocysteine concentration in coronary artery disease: a meta-analysis of randomised controlled trials
A meta-analysis of 377 patients with coronary artery disease found that folic acid supplementation 5 mg daily for greater than 4 weeks significantly improved flow-mediated dilation and lowered plasma homocysteine concentration compared with placebo.
DOI: 10.1136/heartjnl-2013-304613.432 -
Effects of proton pump inhibitors on vitamin B12
A concise review of evidence linking long-term proton pump inhibitor (PPI) use to vitamin B12 deficiency in older adults, summarizing proposed mechanisms, clinical implications, and recommendations for monitoring and management.
DOI: 10.1016/j.maturitas.2014.06.005